Physiological system or category of the primary health condition | All responses n (%) | Specific primary health condition | Responses within the system or category n (%) | Considered important in the management of the primary condition [All responses, n (%)] |
---|---|---|---|---|
Musculoskeletal | 158 (18.5) | Chronic musculoskeletal pain | 76 (48.4) | 151 (17.7) |
Injury | 30 (19.1) | |||
Osteoarthritis | 20 (12.7) | |||
Fibromyalgia or chronic fatigue syndrome | 12 (7.6) | |||
Sciatica | 4 (2.6) | |||
Other | 15 (9.6) | |||
Gastrointestinal | 104 (12.2) | Irritable bowel syndrome | 33 (31.7) | 348 (40.8) |
Gastro-oesophageal reflux | 18 (17.3) | |||
Food allergy/intolerance/sensitivity | 17 (16.4) | |||
Dysbiosis or parasites | 8 (7.7) | |||
Liver and biliary dysfunction and disease | 6 (5.8) | |||
Symptomatic constipation | 3 (2.9) | |||
Symptomatic diarrhoea | 2 (1.9) | |||
Inflammatory bowel disorders | 1 (1.0) | |||
Other | 16 (5.8) | |||
Mental illness | 93 (11.0) | Anxiety | 26 (28.0) | 133 (15.5) |
Depression | 20 (21.5) | |||
Stress or fatigue | 17 (18.3) | |||
Bipolar disorder | 7 (7.5) | |||
ADHD | 6 (6.5) | |||
Insomnia and other sleep disorders | 5 (5.4) | |||
ASD | 2 (2.2) | |||
Addiction | 2 (2.2) | |||
Other | 8 (8.6) | |||
General wellness and prevention | 57 (6.7) | Â | Â | 245 (28.7) |
Female reproductive | 51 (6.0) | Menopausal symptoms | 20 (39.2) | 134 (15.7) |
Dysmenorrhoea and other menstrual complaints | 12 (23.5) | |||
Polycystic ovarian syndrome (PCOS) | 9 (17.7) | |||
Endometriosis | 6 (11.7) | |||
Fibroids and other benign tumours | 3 (5.9) | |||
Other | 1 (2.0) | |||
Skin/Integumentary | 44 (5.2) | Inflammatory skin conditions | 25 (56.8) | 79 (9.3) |
Acne vulgaris | 11 (25.0) | |||
Other | 8 (18.2) | |||
Respiratory | 43 (5.0) | Congestive respiratory disorders | 23 (53.5) | 71 (8.3) |
Respiratory tract infection | 8 (18.6) | |||
Asthma | 6 (14.0) | |||
Other | 6 (14.0) | |||
Maternal health | 43 (5.0) | Fertility | 23 (54.8) | 29 (3.4) |
Pregnancy | 11 (26.2) | |||
Preconception care | 5 (11.9) | |||
Lactation, breastfeeding and other postpartum care | 3 (7.1) | |||
Neurological | 43 (5.0) | Headache/migraine | 24 (55.8) | 67 (7.9) |
Neuralgia | 7 (16.3) | |||
Parkinson’s disease | 3 (7.0 | |||
Paralysis and partial paralysis | 3 (7.0) | |||
Carpel tunnel syndrome | 1 (2.3) | |||
Other | 5 (11.6) | |||
Endocrine | 40 (4.7) | Thyroid abnormalities | 22 (55.0) | 203 (23.8) |
Type 2 diabetes | 5 (12.5) | |||
Adrenal insufficiency | 5 (12.5) | |||
Insulin resistance or metabolic syndrome | 4 (10.0) | |||
Other | 4 (10.0) | |||
Cancer | 39 (4.6) | Active, malignant cancer | 17 (43.6) | 29 (3.4) |
Post-cancer recovery, support and prevention | 11 (28.2) | |||
Management of cancer treatment side effects | 5 (12.8) | |||
Palliative care | 3 (7.7) | |||
Benign cancer | 2 (5.1) | |||
Other | 1 (2.6) | |||
Cardiovascular | 36 (4.2) | Hypertension | 15 (41.7) | 108 (12.7) |
Chronic venous insufficiency/poor circulation | 9 (25.0) | |||
Atherosclerosis and/or dyslipidemia | 6 (16.7) | |||
Stroke-related complaints | 4 (11.1) | |||
Other | 2 (5.6) | |||
Weight management | 34 (4.0) | Â | Â | 147 (17.2) |
Autoimmune | 31 (3.6) | Systemic (e.g. SLE/lupus, Rheumatoid arthritis, ankylosing spondylitis) | 18 (58.1) | 74 (8.7) |
Gastrointestinal (coeliac, crohn’s, ulcerative colitis) | 5 (16.1) | |||
Nervous system (e.g. multiple sclerosis, myasthenia gravis) | 3 (9.7) | |||
Thyroid (e.g. Grave’s, Hashimoto’s) | 2 (6.5) | |||
Type 1 diabetes | 2 (6.5) | |||
Other | 1 (3.2) | |||
Urogenital | 21 (2.5) | Urinary tract infection | 8 (38.1) | 41 (4.8) |
Benign prostate hypertrophy | 5 (23.8) | |||
Kidney disease | 3 (14.3) | |||
Infections (candida, sexually transmitted infections) | 3 (14.3) | |||
Incontinence | 2 (9.5) | |||
Ageing and cognition | 10 (1.2) | Alzheimer’s disease or dementia | 4 (40.0) | 69 (8.1) |
Healthy ageing support | 3 (30.0) | |||
Other cognitive impairment | 3 (30.0) | |||
Infectious disease | 7 (0.8) | Lyme disease | 3 (42.9) | 27 (3.1) |
Epstein-barr virus | 2 (28.6) | |||
Other | 2 (28.6) |